Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ak-0529
2. Ak0529
3. N-((3-aminooxetan-3-yl)methyl)-2-(1,1-dioxo-3,5-dihydro-2h-1lambda6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine
4. Ro-0529
5. Ro0529
1. 1422500-60-4
2. Ak0529
3. Ziresovir [inn]
4. Ro-0529
5. Ak-0529
6. Xcf42d7ag4
7. Chembl4468815
8. 4-(4-(((3-aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine 1,1-dioxide
9. 4-quinazolinamine, N-((3-amino-3-oxetanyl)methyl)-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5h)-yl)-6-methyl-
10. N-((3-amino-3-oxetanyl)methyl)-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5h)-yl)-6-methyl-4-quinazolinamine
11. N-((3-aminooxetan-3-yl)methyl)-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5h)-yl)-6-methylquinazolin-4-amine
12. N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-2h-1lambda6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine
13. N-((3-aminooxetan-3-yl)methyl)-2-(1,1-dioxo-3,5-dihydro-2h-1lambda6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine
14. N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxido-2,3-dihydro-1,4-benzothiazepin-4(5h)-yl)-6-methylquinazolin-4-amine
15. Unii-xcf42d7ag4
16. Ziresovir [who-dd]
17. Schembl14704847
18. Dtxsid901028129
19. Bdbm50516304
20. Db15145
21. Az171068
22. Hy-109142
23. Cs-0086934
24. A937667
25. 4-(4-(((3-aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1h-1.lambda.6,4-benzothiazepine-1,1-dione
26. 4-(4-(((3-aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydro-1h-1lambda6,4-benzothiazepine-1,1-dione
27. 4-(4-(((3-aminooxetan-3-yl)methyl)amino)-6-methylquinazolin-2-yl)-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine1,1-dioxide
| Molecular Weight | 439.5 g/mol |
|---|---|
| Molecular Formula | C22H25N5O3S |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 439.16781085 g/mol |
| Monoisotopic Mass | 439.16781085 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 740 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
67
PharmaCompass offers a list of Ziresovir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ziresovir manufacturer or Ziresovir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ziresovir manufacturer or Ziresovir supplier.
PharmaCompass also assists you with knowing the Ziresovir API Price utilized in the formulation of products. Ziresovir API Price is not always fixed or binding as the Ziresovir Price is obtained through a variety of data sources. The Ziresovir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ziresovir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ziresovir, including repackagers and relabelers. The FDA regulates Ziresovir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ziresovir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ziresovir supplier is an individual or a company that provides Ziresovir active pharmaceutical ingredient (API) or Ziresovir finished formulations upon request. The Ziresovir suppliers may include Ziresovir API manufacturers, exporters, distributors and traders.
Ziresovir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ziresovir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ziresovir GMP manufacturer or Ziresovir GMP API supplier for your needs.
A Ziresovir CoA (Certificate of Analysis) is a formal document that attests to Ziresovir's compliance with Ziresovir specifications and serves as a tool for batch-level quality control.
Ziresovir CoA mostly includes findings from lab analyses of a specific batch. For each Ziresovir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ziresovir may be tested according to a variety of international standards, such as European Pharmacopoeia (Ziresovir EP), Ziresovir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ziresovir USP).
